OR WAIT null SECS
© 2024 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 16, 2023
To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.
February 15, 2023
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.
Growth in outsourcing has been the result of COVID-19 projects taking
precedence, which has pushed some contract manufacturing to second-tier CDMOs.
In the coming year, pharmaceutical innovation will be fueled by key trends throughout the quality sector.
The complexity of the pharmaceutical product brings challenges to the transfer of information and technology between sponsors and contractors.
Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.